Literature DB >> 12584165

Minimal effects of dietary restriction on neuroendocrine carcinogenesis in Rb+/- mice.

Z Dave Sharp1, Wen-Hwa Lee, Alexander Yu Nikitin, Andrea Flesken-Nikitin, Yuji Ikeno, Robert Reddick, Arlan G Richardson, James F Nelson.   

Abstract

The efficacy of dietary restriction in retarding tumor growth is well established in rodents. However, gene and cell lineage specificity of dietary restriction effects is far less defined. Mice with a single copy of the retinoblastoma susceptibility gene (Rb) develop a well-established syndrome of mouse neuroendocrine neoplasia associated with Rb deficiency. Thus, if DR represses tumor growth in this model, it should be unambiguously attributed to the Rb defect in neuroendocrine cell lineages. To address this possibility, Rb(+/-) mice were entered into a diet restriction study. Surprisingly, 40-50% reductions in dietary intake, relative to an ad libitum group, started on either postnatal day 28 or 42 had little to no effect on either the frequency or growth of pituitary tumors either during the latency period (postnatal day 224) or at the time of their natural death. Consistent with cross-section data, survival of 65 diet restricted Rb(+/-) mice was almost identical to that of 67 Rb(+/-) mice fed ad libitum (AL); median life span was 414 and 436 days for AL and DR groups, respectively. These findings indicate that diet restriction provides no significant benefit in delaying growth and progression of neuroendocrine tumors exhibiting loss of RB function. They also introduce the possibility that RB is required for the tumor-repressive effects of DR.

Entities:  

Mesh:

Year:  2003        PMID: 12584165     DOI: 10.1093/carcin/24.2.179

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Aging and cancer: can mTOR inhibitors kill two birds with one drug?

Authors:  Zelton Dave Sharp; Arlan Richardson
Journal:  Target Oncol       Date:  2011-03-11       Impact factor: 4.493

Review 2.  Mechanistic target of rapamycin signaling in mouse models of accelerated aging.

Authors:  Jin Young Lee; Brian K Kennedy; Chen-Yu Liao
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-01       Impact factor: 6.053

Review 3.  Evaluating the beneficial effects of dietary restrictions: A framework for precision nutrigeroscience.

Authors:  Kenneth A Wilson; Manish Chamoli; Tyler A Hilsabeck; Manish Pandey; Sakshi Bansal; Geetanjali Chawla; Pankaj Kapahi
Journal:  Cell Metab       Date:  2021-09-22       Impact factor: 31.373

4.  eRapa restores a normal life span in a FAP mouse model.

Authors:  Paul Hasty; Carolina B Livi; Sherry G Dodds; Diane Jones; Randy Strong; Martin Javors; Kathleen E Fischer; Lauren Sloane; Kruthi Murthy; Gene Hubbard; Lishi Sun; Vincent Hurez; Tyler J Curiel; Zelton Dave Sharp
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-26

Review 5.  The multiple connections between pRB and cell metabolism.

Authors:  Brandon N Nicolay; Nicholas J Dyson
Journal:  Curr Opin Cell Biol       Date:  2013-08-03       Impact factor: 8.382

6.  Rapamycin Extends Life Span in ApcMin/+ Colon Cancer FAP Model.

Authors:  Manish Parihar; Sherry G Dodds; Gene Hubbard; Martin A Javors; Randy Strong; Paul Hasty; Zelton Dave Sharp
Journal:  Clin Colorectal Cancer       Date:  2020-09-15       Impact factor: 4.481

7.  p53 and rapamycin are additive.

Authors:  Barbara Christy; Marco Demaria; Judith Campisi; Jing Huang; Diane Jones; Sherry G Dodds; Charnae Williams; Gene Hubbard; Carolina B Livi; Xiaoli Gao; Susan Weintraub; Tyler Curiel; Z Dave Sharp; Paul Hasty
Journal:  Oncotarget       Date:  2015-06-30

Review 8.  Is Rapamycin a Dietary Restriction Mimetic?

Authors:  Archana Unnikrishnan; Kavitha Kurup; Adam B Salmon; Arlan Richardson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-01       Impact factor: 6.053

Review 9.  Dietary regulation in health and disease.

Authors:  Qi Wu; Zhi-Jie Gao; Xin Yu; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-23

10.  Rapamycin extends life span of Rb1+/- mice by inhibiting neuroendocrine tumors.

Authors:  Carolina B Livi; Rulon L Hardman; Barbara A Christy; Sherry G Dodds; Diane Jones; Charnae Williams; Randy Strong; Alex Bokov; Martin A Javors; Yuji Ikeno; Gene Hubbard; Paul Hasty; Zelton Dave Sharp
Journal:  Aging (Albany NY)       Date:  2013-02       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.